HER2CLIMB-02: Primary Analysis of a Randomized, Double-blind Phase 3 Trial of Tucatinib and Trastuzumab Emtansine for Previously Treated HER2-positive Metastatic Breast Cancer | OncLive
11:33
HER2CLIMB-02: Primary Analysis of a Randomized, Double-blind Phas…
Jan 25, 2024
onclive.com
Dr. Hurvitz on neoMONARCH Trial for HR+ Breast Cancer
2:00
Dr. Hurvitz on neoMONARCH Trial for HR+ Breast Cancer
299 viewsDec 9, 2016
YouTubeOncLive
Trastuzumab Deruxtecan in Patients With HER2 Advanced/Metastatic Breast Cancer With or Without Brain Metastases: DESTINY-Breast12 Primary Results | OncLive
13:05
Trastuzumab Deruxtecan in Patients With HER2 Advanced/Metastatic B…
Nov 27, 2024
onclive.com
TEXT and SOFT Trials
8:17
TEXT and SOFT Trials
1.2K viewsFeb 3, 2015
YouTubeOncLive
Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast Cancer
57:18
Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast Can…
3.4K viewsJul 6, 2022
YouTubePeerView Oncology
Dr. Hurvitz on Steps to Take With HER2-Positive Breast Cancer Research
1:03
Dr. Hurvitz on Steps to Take With HER2-Positive Breast Cancer Res…
363 viewsAug 16, 2016
YouTubeOncLive
Trastuzumab deruxtecan shows benefit across HER2+ metastatic breast cancer subgroups
5:09
Trastuzumab deruxtecan shows benefit across HER2+ metastatic b…
1.1K viewsJan 12, 2022
YouTubeecancer
1:59
Dr. Hurvitz on Patient Outcomes and PIK3CA Mutations
1.6K viewsJul 18, 2014
YouTubeTargeted Oncology
1:36
Dr. Hurvitz on Pembrolizumab for TNBC
582 viewsDec 11, 2014
YouTubeTargeted Oncology
3:45
Evolving Landscape of HER2-Targeted Therapy in Breast Cancer
717 viewsJan 29, 2020
YouTubeOncLive
Adding ribociclib to hormone therapy extends lives of women wi…
Jun 1, 2019
ucla.edu
1:22
Dr. Hurvitz on the Findings of DESTINY-Breast01 in HER2+ Meta…
447 viewsJan 7, 2020
YouTubeOncLive
1:08:15
Hormone Receptor-Positive and HER2-Positive Breast Cancer: A M…
79.4K viewsOct 27, 2015
YouTubeLiving Beyond Breast Cancer
8:40
First-Line Treatment of HER2-Positive Metastatic Breast Cancer
3.6K viewsFeb 11, 2016
YouTubeOncLive
2:44
Ribociclib plus endocrine therapy boosts survival of HR+/HER2- bre…
3.8K viewsJun 4, 2019
YouTubeMDedge: news and insights for busy physicians
1:41
Dr. Hurvitz on Toxicity Associated With Neratinib in HER2+ Breast Ca…
304 viewsMar 26, 2019
YouTubeOncLive
6:38
Metastatic HR+ Breast Cancer: Developments and Approvals
187 viewsJul 19, 2018
YouTubeOncLive
1:26
Dr. Hurvitz on Unmet Needs in HER2+ Breast Cancer
200 viewsAug 12, 2020
YouTubeOncLive
2:03
Dr. Hurvitz on Novel Agents in HER2-Positive Breast Cancer
477 viewsOct 10, 2018
YouTubeOncLive
24:31
Experts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Ca…
34 views8 months ago
YouTubeDecera Clinical Education
3:56
Role of Everolimus in HR+ Metastatic Breast Cancer
1.8K viewsAug 20, 2018
YouTubeOncLive
0:19
New hope for treating aggressive triple negative breast cancer
2 weeks ago
MSNWoman's World
Selecting Between CDK4/6 Inhibitors in Advanced HR /HER2- …
Apr 1, 2022
medscape.com
1:55
Dr. Hurvitz on Novel Emerging Agents in HER2+ Breast Cancer
613 viewsMar 9, 2018
YouTubeOncLive
59:50
From Breast Oncologist to Division Head, Shaping the Future of Patie…
177 viewsMar 25, 2025
YouTubeUWDeptMedicine
1:02:01
Breast Cancer — An ASCO 2025 Review
100 views7 months ago
YouTubeResearch To Practice
7:00
Ribociclib and endocrine therapy improves survival for pre-menopa…
610 viewsJun 20, 2019
YouTubeecancer
2:16
Dr. Hurvitz on the Future of the Treatment of TNBC
211 viewsOct 23, 2014
YouTubeTargeted Oncology
1:29
Dr. Hurvitz on Standards of Care in HER2+ Breast Cancer
180 viewsMar 14, 2019
YouTubeOncLive
5:03
Role of Fulvestrant Monotherapy in HR+ mBC
2.1K viewsAug 10, 2018
YouTubeOncLive
See more videos
Static thumbnail place holder